Neuroblastoma response to RAS-MAPK inhibitors and APR-246 (eprenetapopt) co-treatment is dependent on SLC7A11 - Mlakar, Vid; Oehme, Ina; Lesne, Laurence; Najafi, Sara; Ansari, Marc; Gumy-Pause, Fabienne (Frontiers in Oncology, 2024)